Literature DB >> 17907768

Advanced pharmacokinetic models based on organ clearance, circulatory, and fractal concepts.

K Sandy Pang1, Michael Weiss, Panos Macheras.   

Abstract

Three advanced models of pharmacokinetics are described. In the first class are physiologically based pharmacokinetic models based on in vitro data on transport and metabolism. The information is translated as transporter and enzyme activities and their attendant heterogeneities into liver and intestine models. Second are circulatory models based on transit time distribution and plasma concentration time curves. The third are fractal models for nonhomogeneous systems and non-Fickian processes are presented. The usefulness of these pharmacokinetic models, with examples, is compared.

Mesh:

Substances:

Year:  2007        PMID: 17907768      PMCID: PMC2751417          DOI: 10.1208/aapsj0902030

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  127 in total

1.  Sulfation is rate limiting in the futile cycling between estrone and estrone sulfate in enriched periportal and perivenous rat hepatocytes.

Authors:  E Tan; K S Pang
Journal:  Drug Metab Dispos       Date:  2001-03       Impact factor: 3.922

2.  Segmental intestinal transporters and metabolic enzymes on intestinal drug absorption.

Authors:  Debbie Tam; Rommel G Tirona; K Sandy Pang
Journal:  Drug Metab Dispos       Date:  2003-04       Impact factor: 3.922

3.  On the use of the Weibull function for the discernment of drug release mechanisms.

Authors:  Vasiliki Papadopoulou; Kosmas Kosmidis; Marilena Vlachou; Panos Macheras
Journal:  Int J Pharm       Date:  2005-12-20       Impact factor: 5.875

4.  Circulatory transport and capillary-tissue exchange as determinants of the distribution kinetics of inulin and antipyrine in dog.

Authors:  Michael Weiss; Tom C Krejcie; Michael J Avram
Journal:  J Pharm Sci       Date:  2007-04       Impact factor: 3.534

5.  Effects of cardiac output on disposition kinetics of sorbitol: recirculatory modelling.

Authors:  M Weiss; G H Hübner; I G Hübner; W Teichmann
Journal:  Br J Clin Pharmacol       Date:  1996-04       Impact factor: 4.335

6.  Membrane localization of the electrogenic cation transporter rOCT1 in rat liver.

Authors:  F Meyer-Wentrup; U Karbach; V Gorboulev; P Arndt; H Koepsell
Journal:  Biochem Biophys Res Commun       Date:  1998-07-30       Impact factor: 3.575

7.  A linear recirculation model for drug disposition.

Authors:  D J Cutler
Journal:  J Pharmacokinet Biopharm       Date:  1979-02

8.  Fractal volume of drug distribution: it scales proportionally to body mass.

Authors:  V Karalis; L Claret; A Iliadis; P Macheras
Journal:  Pharm Res       Date:  2001-07       Impact factor: 4.200

9.  Enhanced expression of basolateral multidrug resistance protein isoforms Mrp3 and Mrp5 in rat liver by LPS.

Authors:  Markus G Donner; Ulrich Warskulat; Nirmalendu Saha; Dieter Häussinger
Journal:  Biol Chem       Date:  2004 Mar-Apr       Impact factor: 3.915

10.  Heterogeneous expression of sulphotransferases in periportal and perivenous hepatocytes prepared from male and female rat liver.

Authors:  D Tosh; E B Borthwick; S Sharp; A Burchell; B Burchell; M W Coughtrie
Journal:  Biochem Pharmacol       Date:  1996-02-09       Impact factor: 5.858

View more
  13 in total

Review 1.  Long-lasting target binding and rebinding as mechanisms to prolong in vivo drug action.

Authors:  Georges Vauquelin; Steven J Charlton
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

Review 2.  Reproducible pharmacokinetics.

Authors:  John P A Ioannidis
Journal:  J Pharmacokinet Pharmacodyn       Date:  2019-04-19       Impact factor: 2.745

3.  Tissue-level modeling of xenobiotic metabolism in liver: An emerging tool for enabling clinical translational research.

Authors:  Marianthi G Lerapetritou; Panos G Georgopoulos; Charles M Roth; Loannis P Androulakis
Journal:  Clin Transl Sci       Date:  2009-06       Impact factor: 4.689

4.  Drug Transporters in Xenobiotic Disposition and Pharmacokinetic Prediction.

Authors:  Qingcheng Mao; Yurong Lai; Joanne Wang
Journal:  Drug Metab Dispos       Date:  2018-05       Impact factor: 3.922

5.  Using modeling to help understand vaginal microbicide functionality and create better products.

Authors:  David F Katz; Yajing Gao; Meng Kang
Journal:  Drug Deliv Transl Res       Date:  2011-05-17       Impact factor: 4.617

6.  The virtual cell based assay: Current status and future perspectives.

Authors:  Rabea Graepel; Lara Lamon; David Asturiol; Elisabet Berggren; Elisabeth Joossens; Alicia Paini; Pilar Prieto; Maurice Whelan; Andrew Worth
Journal:  Toxicol In Vitro       Date:  2017-01-18       Impact factor: 3.500

7.  A multi-scale modeling framework for individualized, spatiotemporal prediction of drug effects and toxicological risk.

Authors:  Juan G Diaz Ochoa; Joachim Bucher; Alexandre R R Péry; José M Zaldivar Comenges; Jens Niklas; Klaus Mauch
Journal:  Front Pharmacol       Date:  2013-01-22       Impact factor: 5.810

8.  Representative Sinusoids for Hepatic Four-Scale Pharmacokinetics Simulations.

Authors:  Lars Ole Schwen; Arne Schenk; Clemens Kreutz; Jens Timmer; María Matilde Bartolomé Rodríguez; Lars Kuepfer; Tobias Preusser
Journal:  PLoS One       Date:  2015-07-29       Impact factor: 3.240

9.  Spatio-temporal simulation of first pass drug perfusion in the liver.

Authors:  Lars Ole Schwen; Markus Krauss; Christoph Niederalt; Felix Gremse; Fabian Kiessling; Andrea Schenk; Tobias Preusser; Lars Kuepfer
Journal:  PLoS Comput Biol       Date:  2014-03-13       Impact factor: 4.475

10.  A physiologically-based flow network model for hepatic drug elimination III: 2D/3D DLA lobule models.

Authors:  Vahid Rezania; Dennis Coombe; Jack A Tuszynski
Journal:  Theor Biol Med Model       Date:  2016-03-03       Impact factor: 2.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.